XXXiaoyu Xia

Xiaoyu Xia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaoyu Xia has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An HDG11-mediated transcriptional network regulates 1-deoxynojirimycin biosynthesis in mulberry

    by Zhen Yang, Shuo Zhao, Yan Li, Yeling Wei, Zhonghao Wang, Xiaoyu Xia, Dong Li, Ningjia He

    1-Deoxynojirimycin (DNJ) is an iminosugar with notable pharmacological properties, and mulberry (Morus spp.) represents the richest natural source of this compound, particularly in young leaves and roots. Despite its tissue-specific distribution, the transcriptional regulatory mechanisms underlying its biosynthesis remain poorly understood. In this study, we integrated transcriptomic profiling, molecular assays, and phytohormone analyses to uncover a multilayered transcriptional network controlling DNJ biosynthesis in mulberry. Weighted gene co-expression network analysis identified a DNJ-associated module (MEblue) that includes 4 potential transcription factors: zinc-finger homeodomain-6 (ZFHD6), HOMEODOMAIN GLABROUS11 (HDG11), TEOSINTE BRANCHED1/CYCLOIDEA/PROLIFERATING CELL FACTOR-14 (TCP14), and ARABIDOPSIS THALIANA HOMEBOX-40 (ATHB40). ZFHD6, TCP14, and ATHB40 directly interacted with and activated the MnGutB1 promoter, a key biosynthetic gene. Although HDG11 did not target MnGutB1 directly, it transcriptionally activated ZFHD6, TCP14, and ATHB40, and formed protein complexes with TCP14 or ATHB40, thereby indirectly promoting DNJ biosynthesis. Furthermore, exogenous application of trans-zeatin riboside or abscisic acid induced HDG11 and MnGutB1 expression, concomitant with elevated DNJ levels. Our findings identify an HDG11-centered regulatory hierarchy that integrates phytohormonal and developmental signals to regulate DNJ biosynthesis, offering insights for metabolic engineering of DNJ production in plants.


  • Dehydrogenase MnGutB1 catalyzes 1-deoxynojirimycin biosynthesis in mulberry

    by Zhen Yang, Yiwei Luo, Xiaoyu Xia, Jinzhi He, Jiajia Zhang, Qiwei Zeng, Dong Li, Bi Ma, Shaoyu Zhang, Changxin Zhai, et al.

    As the prevalence of diabetes continues to increase, the number of individuals living with diabetes complications will reach an unprecedented magnitude. Continuous use of some synthetic agents to reduce blood glucose levels causes severe side effects, and thus, the demand for nontoxic, affordable drugs persists. Naturally occurring compounds, such as iminosugars derived from the mulberry (Morus spp.), have been shown to reduce blood glucose levels. In mulberry, 1-deoxynojirimycin (DNJ) is the predominant iminosugar. However, the mechanism underlying DNJ biosynthesis is not completely understood. Here, we showed that DNJ in mulberry is derived from sugar and catalyzed through 2-amino-2-deoxy-D-mannitol (ADM) dehydrogenase MnGutB1. Combining both targeted and nontargeted metabolite profiling methods, DNJ and its precursors ADM and nojirimycin (NJ) were quantified in mulberry samples from different tissues. Purified His-tagged MnGutB1 oxidized the hexose derivative ADM to form the 6-oxo compound DNJ. The mutant MnGutB1 D283N lost this remarkable capability. Furthermore, in contrast to virus-induced gene silencing of MnGutB1 in mulberry leaves that disrupted the biosynthesis of DNJ, overexpression of MnGutB1 in hairy roots and light-induced upregulation of MnGutB1 enhanced DNJ accumulation. Our results demonstrated that hexose derivative ADM, rather than lysine derivatives, is the precursor in DNJ biosynthesis, and it is catalyzed by MnGutB1 to form the 6-oxo compound. These results represent a breakthrough in producing DNJ and its analogs for medical use by metabolic engineering or synthetic biology.